|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Freitas AC, Gomes Leitão MC and Coimbra
EC: Prospects of molecularly-targeted therapies for cervical cancer
treatment. Curr Drug Targets. 16:77–91. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scheurer ME, Tortolero-Luna G and
Adler-Storthz K: Human papillomavirus infection: Biology,
epidemiology, and prevention. Int J Gynecol Cancer. 15:727–746.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castellsagué X, Naud P, Chow SN, Wheeler
CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM,
Salmerón J, et al: Risk of newly detected infections and cervical
abnormalities in women seropositive for naturally acquired human
papillomavirus type 16/18 antibodies: Analysis of the control arm
of PATRICIA. J Infect Dis. 210:517–534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murchison EP, Stein P, Xuan Z, Pan H,
Zhang MQ, Schultz RM and Hannon GJ: Critical roles for Dicer in the
female germline. Genes Dev. 21:682–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Magnusson PK, Lichtenstein P and
Gyllensten UB: Heritability of cervical tumours. Int J Cancer.
88:698–701. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu M, Jolicoeur N, Li Z, Zhang L, Fortin
Y, L'Abbe D, Yu Z and Shen SH: Genetic variations of microRNAs in
human cancer and their effects on the expression of miRNAs.
Carcinogenesis. 29:1710–1716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jazdzewski K, Murray EL, Franssila K,
Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in
pre-miR-146a decreases mature miR expression and predisposes to
papillary thyroid carcinoma. Proc Natl Acad Sci USA. 105:7269–7274.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zavala V, Pérez-Moreno E, Tapia T, Camus M
and Carvallo P: miR-146a and miR-638 in BRCA1-deficient triple
negative breast cancer tumors, as potential biomarkers for improved
overall survival. Cancer Biomark. 16:99–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu R, Liu C, Chen D, Yang WH, Liu X, Liu
CG, Dugas CM, Tang F, Zheng P, Liu Y, et al: FOXP3 Controls an
miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in
Breast Cancer Cells. Cancer Res. 75:1703–1713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang S, Liu F, Mao X, Huang J, Yang J,
Yin X, Wu L, Zheng L and Wang Q: Elevation of miR-27b by HPV16 E7
inhibits PPARγ expression and promotes proliferation and invasion
in cervical carcinoma cells. Int J Oncol. 47:1759–1766. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu F, Zhang S, Zhao Z, Mao X, Huang J, Wu
Z, Zheng L and Wang Q: MicroRNA-27b up-regulated by human
papillomavirus 16 E7 promotes proliferation and suppresses
apoptosis by targeting polo-like kinase2 in cervical cancer.
Oncotarget. 7:19666–19679. 2016.PubMed/NCBI
|
|
16
|
Peralta-Zaragoza O, Deas J, Meneses-Acosta
A, De la O-Gómez F, Fernández-Tilapa G, Gómez-Cerón C,
Benítez-Boijseauneau O, Burguete-García A, Torres-Poveda K,
Bermúdez-Morales VH, et al: Relevance of miR-21 in regulation of
tumor suppressor gene PTEN in human cervical cancer cells. BMC
Cancer. 16:2152016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW,
Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical cancer
cell transformation through regulation of β-catenin via a
SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis.
35:1931–1940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou X, Yue Y, Wang R, Gong B and Duan Z:
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer
stem cells. Int J Oncol. 50:853–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hwang WL, Jiang JK, Yang SH, Huang TS, Lan
HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW, et al:
MicroRNA-146a directs the symmetric division of Snail-dominant
colorectal cancer stem cells. Nat Cell Biol. 16:268–280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park H, Huang X, Lu C, Cairo MS and Zhou
X: MicroRNA-146a and microRNA-146b regulate human dendritic cell
apoptosis and cytokine production by targeting TRAF6 and IRAK1
proteins. J Biol Chem. 290:2831–2841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perry MM, Moschos SA, Williams AE,
Shepherd NJ, Larner-Svensson HM and Lindsay MA: Rapid changes in
microRNA-146a expression negatively regulate the IL-1beta-induced
inflammatory response in human lung alveolar epithelial cells. J
Immunol. 180:5689–5698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Contreras JR, Palanichamy JK, Tran TM,
Fernando TR, Rodriguez-Malave NI, Goswami N, Arboleda VA, Casero D
and Rao DS: MicroRNA-146a modulates B-cell oncogenesis by
regulating Egr1. Oncotarget. 6:11023–11037. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou J, Wang P, Lin L, Liu X, Ma F, An H,
Wang Z and Cao X: MicroRNA-146a feedback inhibits RIG-I-dependent
Type I IFN production in macrophages by targeting TRAF6, IRAK1, and
IRAK2. J Immunol. 183:2150–2158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito-Kureha T, Koshikawa N, Yamamoto M,
Semba K, Yamaguchi N, Yamamoto T, Seiki M and Inoue J: Tropomodulin
1 expression driven by NF-κB enhances breast cancer growth. Cancer
Res. 75:62–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kastrati I, Canestrari E and Frasor J:
PHLDA1 expression is controlled by an estrogen
receptor-NFκB-miR-181 regulatory loop and is essential for
formation of ER+ mammospheres. Oncogene. 34:2309–2316.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-146a inhibits proliferation, migration and
invasion of human cervical and colorectal cancer cells. Biochem
Biophys Res Commun. 480:528–533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duan R, Pak C and Jin P: Single nucleotide
polymorphism associated with mature miR-125a alters the processing
of pri-miRNA. Hum Mol Genet. 16:1124–1131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yue C, Wang M, Ding B, Wang W, Fu S, Zhou
D, Zhang Z and Han S: Polymorphism of the pre-miR-146a is
associated with risk of cervical cancer in a Chinese population.
Gynecol Oncol. 122:33–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sarkar FH, Li Y, Wang Z and Kong D:
Cellular signaling perturbation by natural products. Cell Signal.
21:1541–1547. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin Y, Bai L, Chen W and Xu S: The
NF-kappaB activation pathways, emerging molecular targets for
cancer prevention and therapy. Expert Opin Ther Targets. 14:45–55.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JE, Kim SY, Lim SY, Kieff E and Song
YJ: Role of Ca2+/calmodulin-dependent kinase II-IRAK1
interaction in LMP1-induced NF-κB activation. Mol Cell Biol.
34:325–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L,
Kalbfleisch JH, Gao X, Kao RL, Williams DL, et al: Attenuation of
cardiac dysfunction in polymicrobial sepsis by microRNA-146a is
mediated via targeting of IRAK1 and TRAF6 expression. J Immunol.
195:672–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
